High Plasma Fibrinogen is Correlated With Poor Response to Trastuzumab Treatment in HER2 Positive Breast Cancer

Some of HER-2 positive breast cancer patients failed to trastuzumab treatment. Recent reports have indicated the correlation between plasma coagulation parameters and clinical characteristics in breast cancer. The aim of this study was to analyze the role of coagulation parameters in trastuzumab tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu-Lin, Lu, Qing, Liang, Ji-Wei, Xia, Yu, Zhang, Wei, Hu, Bao-Quan, Shang, Fang-Fang, Ji, You-Ran, Wang, Jun, Wang, Qiang, Liang, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602707/
https://www.ncbi.nlm.nih.gov/pubmed/25654390
http://dx.doi.org/10.1097/MD.0000000000000481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602707/
https://www.ncbi.nlm.nih.gov/pubmed/25654390
http://dx.doi.org/10.1097/MD.0000000000000481

Ejemplares similares